· Periodic Report
Q3 operating profit KRW 0.8 billion, up 12.1% from a year earlier
Celomax Science sold KRW 4.9 billion in Q3 and earned KRW 0.8 billion from its main business, up 12.1% from a year earlier and down 15.8% from the prior quarter.
471820 · KOSDAQ · Based on DART filings
1 total · 20 per page
· Periodic Report
Celomax Science sold KRW 4.9 billion in Q3 and earned KRW 0.8 billion from its main business, up 12.1% from a year earlier and down 15.8% from the prior quarter.
Get app alerts for new disclosures from Cellromax Science Co., Ltd..